Avantor Investor Conference Presentation Deck

...and is now a global life sciences leader ENTERPRISE VALUE OF ~$23B¹ CASH GENERATION OF >$850M¹ Navantor™ REVENUE OF ~$6.4B¹ 1. FY20 estimate ~70% OF REVENUE IN LIFE SCIENCES AVTR LISTED NYSE 39th Annual J.P. Morgan Healthcare Conference 5

View entire presentation